135 related articles for article (PubMed ID: 32142919)
1. miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.
Molist C; Navarro N; Giralt I; Zarzosa P; Gallo-Oller G; Pons G; Magdaleno A; Moreno L; Guillén G; Hladun R; Garrido M; Soriano A; Segura MF; Sánchez de Toledo J; Gallego S; Roma J
Cancer Lett; 2020 May; 477():49-59. PubMed ID: 32142919
[TBL] [Abstract][Full Text] [Related]
2. Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation.
Sun M; Huang F; Yu D; Zhang Y; Xu H; Zhang L; Li L; Dong L; Guo L; Wang S
Cell Death Dis; 2015 Aug; 6(8):e1859. PubMed ID: 26291313
[TBL] [Abstract][Full Text] [Related]
3. MiR-7 mediates mitochondrial impairment to trigger apoptosis and necroptosis in Rhabdomyosarcoma.
Yang L; Kong D; He M; Gong J; Nie Y; Tai S; Teng CB
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118826. PubMed ID: 32810522
[TBL] [Abstract][Full Text] [Related]
4. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.
Xu TJ; Qiu P; Zhang YB; Yu SY; Xu GM; Yang W
Hum Cell; 2019 Oct; 32(4):548-556. PubMed ID: 31489579
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma.
Sun MM; Li JF; Guo LL; Xiao HT; Dong L; Wang F; Huang FB; Cao D; Qin T; Yin XH; Li JM; Wang SL
Oncogene; 2014 Apr; 33(16):2075-86. PubMed ID: 23665678
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.
Zhang J; Na S; Liu C; Pan S; Cai J; Qiu J
Tumour Biol; 2016 May; 37(5):5941-9. PubMed ID: 26596831
[TBL] [Abstract][Full Text] [Related]
7. Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells.
Masià A; Almazán-Moga A; Velasco P; Reventós J; Torán N; Sánchez de Toledo J; Roma J; Gallego S
Br J Cancer; 2012 Oct; 107(8):1374-83. PubMed ID: 22976797
[TBL] [Abstract][Full Text] [Related]
8. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract][Full Text] [Related]
9. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
[TBL] [Abstract][Full Text] [Related]
10. FAK Signaling in Rhabdomyosarcoma.
Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
[TBL] [Abstract][Full Text] [Related]
11. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
12. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.
Taulli R; Bersani F; Foglizzo V; Linari A; Vigna E; Ladanyi M; Tuschl T; Ponzetto C
J Clin Invest; 2009 Aug; 119(8):2366-78. PubMed ID: 19620785
[TBL] [Abstract][Full Text] [Related]
13. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
14. The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486.
Ghamloush F; Ghayad SE; Rammal G; Fahs A; Ayoub AJ; Merabi Z; Harajly M; Zalzali H; Saab R
Sci Rep; 2019 Oct; 9(1):14242. PubMed ID: 31578374
[TBL] [Abstract][Full Text] [Related]
15. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
[TBL] [Abstract][Full Text] [Related]
16. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
18. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
19. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
20. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]